What is MCRB's P/E ratio?

SERES THERAPEUTICS INC (MCRB) currently trades at a P/E ratio of 9.02.

SERES THERAPEUTICS INC reports a Return on Equity (ROE) of -176.98%.

What is MCRB's dividend yield?

SERES THERAPEUTICS INC offers a dividend yield of 0.00%.

What is MCRB's Deepscope Quality Score?

Deepscope rates MCRB's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MCRB?

Deepscope's AI Timing Score for MCRB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MCRB belong to?

SERES THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

MCRB (NASDAQ) Stock Analysis | SERES THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-02 | FS: 2026-03-31)

MCRB

SERES THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 86

USD 7.33

-0.31 (-4.06%) Day Change

Watchlist Portfolio Compare Chart

9.02

P/E

0.41

D/E

-177.0%

ROE

-39.9%

ROA

0.00%

Div Yield

-0.17

PEG

SERES THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 7.33 Price -0.31 (-4.06%) Day Change	NEWS SCORE: 86

MCRB, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.16 From 30 days period
News Score	86
Magic Formula Rank by ROA	820
Magic Formula Rank by ROE	820
Magic Formula Rank by ROIC	1137
Price	7.33
PBV / Sector	2.79 / 4.53
Earning Per Share	-4.65

PE / Sector	9.02 / 16.80 GREAT
PEG or PE/Growth / Sector	-0.17 / 0.51
Average 1M Daily Value	0.31 M GREAT
Average 1W Daily Value	0.27 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4,088.84 / 450.37
NPM Average (%) / Sector	-1,741.61 / -1,506.30
NPM Change Average (%) / Sector	N/A / 4,941.44
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-39.87 / 30.83
ROA Average (%) / Sector	-48.80 / -347.12
ROA Change Average (%) / Sector	-249.14 / 5,126.35
ROE (%) / Sector	-176.98 / -3.04
ROE Average (%) / Sector	-658.77 / 40.76
ROE Change Average (%) / Sector	-551.37 / 2,110.63
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.43

Registration Details

Analyze Date	2026-06-03 09:11:49
Symbol	MCRB
Name	SERES THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	9.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	73.99 / 8,614.17

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 101 Cambridgepark Drive, Cambridge, MA, United States, 02140

Phone: 617 945 9626

Website: https://www.serestherapeutics.com

Employees: 66

Sector: Healthcare >> Biotechnology

Description: Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.